Search is Powered by Google
Urology / Nephrology News

Intravesical Chondroitin Sulphate Shows Promise For Treatment Of Bladder Pain Syndrome

Main Category: Urology / Nephrology
Also Included In: Pain / Anesthetics
Article Date: 13 Oct 2008 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:4 stars

4 (1 votes)

Health Professional:not yet rated

Article Opinions: 1 posts

UroToday.com - One of the best studied 'naturally occurring' glycosaminoglycans in bladder pain syndrome has been chondroitin sulphate. Studies have indicated a deficit of this proteoglycan in the bladder uroepthelium in BPS. Curtis Nickel from Kingston, Ontario and his Canadian colleagues reported on a multicenter, community based, open-label, uncontrolled study designed to assess the efficacy and safety of intravesical sodium chondroitin sulphate for BPS.

The less-restrictive National Institutes of Health Interstitial Cystitis Database Study definition of interstitial cystitis was the operative definition. Patients must have had urinary/bladder pain/discomfort and urinary frequency/urgency persisting for more than 24 weeks with a negative urine culture and no other obvious cause for the symptom complex. Two percent solution of sodium chondroitin sulphate was instilled by urinary catheter weekly for 6 weeks and then monthly for 16 weeks. A seven point global response assessment was the primary endpoint requiring marked or moderate improvement to qualify as a success.

In all, at week 10, 47% of patients were responders. The O'Leary Sant symptom score decreased by a mean of 5 points and the O'Leary Sant problem score decreased by a mean of 4.3 points. The responder rate increased to 60.4% at week 24. Twenty-eight patients reported 65 adverse events, all mild, and only 20 of those were considered possibly related to treatment. No safety issues were identified.

While open-label trials are notoriously unreliable in the study of BPS treatments, this study does show proof of concept and suggests the need and rationale for a well-powered, randomized, placebo-controlled trial of intravesical chondroitin sulphate for BPS.

Nickel JC, Egerdie B, Downey J, Singh R, Skehan A, Carr L, Irvine-Bird K
BJU Int. 2008 Sep 3. Epub ahead of print
10.1111/j.1464-410X.2008.08028.x

Written by UroToday.com Contributing Editor Philip M. Hanno, MD, MPH

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
40Over40: A New Campaign To Tackle Low Awareness Of Erectile Dysfunction And Its Health Implications In Younger Men
24 Jun 2008
A new survey of 1,000 men aged over 40, commissioned by Eli Lilly and Company Limited (Lilly UK) as part of a new erectile dysfunction awareness campaign, 40over40, reveals that just over 10% of men in their early 40s are...


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

View more videos...